AdvanBio logo — AdvanBio, a subsidiary of Autobio, is committed to the advan...

AdvanBio

AdvanBio, a subsidiary of Autobio, is committed to the advancement of medical laboratory technology.

Founded 2021 United States Irvine, United States 15 employees Biotechnology

General Information

Company Name AdvanBio
Founded Year 2021
Location United States Irvine, United States +1
Employees 15
Industries Biotechnology
Social

Get notified when AdvanBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AdvanBio

AdvanBio is a fast-growing biotechnological company based in Irvine, CA. Established in 2021, it is a subsidiary of Autobio Diagnostics in the U.S. Specializing in providing cutting-edge IVD Quality Control products & Reagents designed for a diverse range of analytes, AdvanBio is committed to advancing medical laboratory technology and dedicated to the promotion of human health. Their services include FDA Submission, Assay Development, Product Sales, and New Technology/Biomarker Development. Empowering medical providers in making pivotal biomarker & diagnostic decisions with their portfolio of innovative technologies, AdvanBio is at the forefront of the Biotechnology industry. The company's slogan, "AdvanBio, a subsidiary of Autobio, is committed to the advancement of medical laboratory technology." embodies their mission. With a focus on IVD Critical Raw Materials, AdvanBio aims to provide global partners with high-performance solutions. As a subsidiary of Autobio, the company benefits from a strong foundation and expertise in the field. With its dedication to innovation and advancement, AdvanBio is poised to make significant contributions to the biotechnological landscape. Overall, AdvanBio's commitment to cutting-edge technology and its potential to impact the medical and biotechnological industries make it a compelling prospect for venture capital investment. As the company continues to grow and make strides in the field of medical laboratory technology, it presents an exciting opportunity for potential investors looking to support innovation and advancements in healthcare. #AdvanBio#ADLM

Taxonomy: IVD Quality Control, Reagents, FDA Submission, Assay Development, Product Sales, Biomarker Development, Diagnostic Decisions, Bioanalysis, Regulatory Consultation, Validation Services

No funding data available for AdvanBio yet.

Get notified when AdvanBio raises funding

AdvanBio Alternatives & Competitors

AdvanBio vs

Cancer: a word, not a sentence!

Series D
32 employees
Biotechnology, Health Care
AdvanBio vs
Nova Biomedical
Nova Biomedical United States

A world leader in critical care and point-of-care testing.

1050 employees
AdvanBio vs
Denovo Biopharma
Denovo Biopharma United States

A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a priva...

Grant
29 employees
Biopharma, Biotechnology

FAQ About AdvanBio

AdvanBio, a subsidiary of Autobio, is committed to the advancement of medical laboratory technology.
AdvanBio was founded in 2021.
AdvanBio is headquartered in Irvine, United States.
AdvanBio operates in the following industries: Biotechnology.
AdvanBio has approximately 15 employees.
Top alternatives and competitors to AdvanBio include Geneseeq Technology Inc., Nova Biomedical, Denovo Biopharma, MNCHIP, DNAlytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AdvanBio and Geneseeq Technology Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AdvanBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes